Mechanical Partitioning of mTORC2 to Direct Mesenchymal Stem Cell Fate
Mechanical Partitioning of mTORC2 to Direct Mesenchymal Stem Cell Fate
批准号:
9099270
负责人:
William Roy Thompson
金额:
$46.64万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-10 至 2020-05-31
关键词:
ActinsAdipocytesAdolescentAffectAgingAmericanBiological AssayBone MarrowCardiovascular DiseasesCell LineageChemicalsChildComplementComplexCytoskeletal ModelingCytoskeletonDataDevelopmentDiseaseElderlyEquilibriumEstrogensEventExerciseFRAP1 geneFatty acid glycerol estersFocal AdhesionsFractureFutureGuanineGuanine Nucleotide Exchange FactorsHealthIn VitroIntegrin beta ChainsIntegrinsMalignant NeoplasmsMarrowMechanicsMediatingMesenchymal Stem CellsModificationMolecular MotorsMotorMovementMyosin ATPaseNon-Insulin-Dependent Diabetes MellitusNuclearObesityOsteogenesisOsteoporosisOverweightPTK2 genePhosphorylationPhosphorylation SitePhosphotransferasesProcessProteinsPsychological reinforcementRecruitment ActivityRegulationRepressionRibosomal Protein S6 KinaseRiskRoleSignal PathwaySignal TransductionSiteSite-Directed MutagenesisSkeletonSmall Interfering RNAStress FibersStructureUnited StatesWalkingWestern BlottingWorkbasebeta cateninbonebone cellbone healthbone qualitydesigndisabilityexercise interventionin vivoknock-downlifetime risklipid biosynthesisobesity in childrenosteogenicpreventpublic health relevanceresponserhosedentary lifestyleskeletalstem cell differentiationstem cell fateupstream kinase
中文摘要
英文摘要
DESCRIPTION (provided by applicant): Spatial, chemical, and mechanical signals all contribute to lineage allocation of pluripotent mesenchymal stem cells (MSCs). When the fate of MSCs tips in favor of adipogenesis and away from osteogenesis in conditions such as unloading, aging, or estrogen deficiency, bone quality is diminished and risk of fracture increases. Dynamic skeletal loading inhibits adipogenesis in vitro and in vivo by enhancing β-catenin activity in MSCs. MSC potential is preserved by a signaling pathway, which is initiated at focal adhesions (FAs) setting off a cascade of ↑Fyn/FAK to ↑mTORC2 to ↑Akt to ↓GSK3β and ↑β-catenin. We have shown that mechanical strain recruits mTORC2 and Akt to FAs; however, the mechanisms responsible for this intracellular signal partitioning and the specific activation sites of mTORC2 subunits are unknown. Preliminary work suggests that strain induces an association of mTORC2 with myosin motors. Just as other intracellular "cargo", including β- integrins, attach to myosins to be transported to FAs, myosins may enable recruitment of mTORC2 to FAs in response to mechanical force. We have also shown that Fyn and mTORC2/Akt participate in mechanically regulated activation of RhoA; however, preliminary work suggests that GEF or GAP intermediaries may be required for RhoA-induced cytoskeletal reorganization and adipogenic repression. The focus of this proposal will be to examine the regulatory modifications of mTORC2-specific subunits and to determine how strain recruits mTORC2 to FAs to be activated. Additionally, we will ask how mTORC2/Akt regulate GEF and GAP RhoA effectors to auto-regulate the cytoskeleton in response to physical force. The proposed hypotheses will be examined through the following specific aims: 1) determine how mTORC2 is activated by mechanical strain; 2) identify mechanisms by which mTORC2 regulates cytoskeletal reorganization. Pharmacological inhibition/knockdown studies will be performed using primary marrow-derived MSCs to examine myosin- mediated mTORC2 FA recruitment, to identify mechanically responsive phosphorylation sites on mTORC2 subunits, and to determine how these modifications influence cytoskeletal remodeling. Additionally, RhoA, GEF, and GAP pull down assays will be employed to study the effects of force on modulators of cytoskeletal adaptation. These studies have implications for understanding the mechanisms by which mechanical loading regulates cytoskeletal assembly and reinforcement, a process essential for proper regulation of mechanosensation and MSC lineage fate. As such, this work will inform the design of future strategies for using exercise to affect development of fat and bone.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1002/jbm4.10529
发表时间:
2021-09
期刊:
JBMR plus
影响因子:
3.8
作者:
[Edwards DF 3rd, Miller CJ, Quintana-Martinez A, Wright CS, Prideaux M, Atkins GJ, Thompson WR, Clinkenbeard EL]
通讯作者:
Clinkenbeard EL
DOI:
10.1007/s11914-020-00647-7
发表时间:
2021-04
期刊:
Current osteoporosis reports
影响因子:
4.3
作者:
[Wright CS, Robling AG, Farach-Carson MC, Thompson WR]
通讯作者:
Thompson WR
Osteocyte Mechanotransduction and the Gabapentin-Sensitive Matrix-Channel Tethering Complex
-
批准号:10428360
-
项目类别:
-
资助金额:$59.41万
-
财政年份:2018
-
负责人:William Roy Thompson
-
依托单位:
Osteocyte Mechanotransduction and the Gabapentin-Sensitive Matrix-Channel Tethering Complex
-
批准号:10192665
-
项目类别:
-
资助金额:$56.5万
-
财政年份:2018
-
负责人:William Roy Thompson
-
依托单位:
Osteocyte Mechanotransduction and the Gabapentin-Sensitive Matrix-Channel Tethering Complex
-
批准号:9789654
-
项目类别:
-
资助金额:$57.7万
-
财政年份:2018
-
负责人:William Roy Thompson
-
依托单位:
Role of mechanically activated Src/mTORC2 signaling on cytoskeletal adaptation
-
批准号:8457722
-
项目类别:
-
资助金额:$5.39万
-
财政年份:2013
-
负责人:William Roy Thompson
-
依托单位:
Role of mechanically activated Src/mTORC2 signaling on cytoskeletal adaptation
-
批准号:8601625
-
项目类别:
-
资助金额:$4.06万
-
财政年份:2013
-
负责人:William Roy Thompson
-
依托单位:
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位: